Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChAd63 PvDBP and MVA PvDBP Vaccine Efficacy in Malaria
NCT04009096Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Jul 2019
- Primary completion
- Jul 2022
- Modality
- Viral Vector Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of ChAd63 PvDBP, MVA PvDBP in malaria, sponsored by University of Oxford. Started Jul 2019; status: completed.
02
Drugs
ChAd63 PvDBPMVA PvDBP
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04009096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04009096.